Literature DB >> 27974462

Down-regulation of microRNA-451a facilitates the activation and proliferation of CD4+ T cells by targeting Myc in patients with dilated cardiomyopathy.

Zhipeng Zeng1, Ke Wang1, Yuanyuan Li1, Ni Xia1, Shaofang Nie1, Bingjie Lv1, Min Zhang1, Xin Tu2, Qianqian Li2, Tingting Tang3, Xiang Cheng4.   

Abstract

CD4+ T cells are abnormally activated in patients with dilated cardiomyopathy (DCM) and might be associated with the immunopathogenesis of the disease. However, the underlying mechanisms of CD4+ T cell activation remain largely undefined. Our aim was to investigate whether the dysregulation of microRNAs (miRNAs) was associated with CD4+ T cell activation in DCM. CD4+ T cells from DCM patients showed increased expression levels of CD25 and CD69 and enhanced proliferation in response to anti-CD3/28, indicating an activated state. miRNA profiling analysis of magnetically sorted CD4+ T cells revealed a distinct pattern of miRNA expression in CD4+ T cells from DCM patients compared with controls. The level of miRNA-451a (miR-451a) was significantly decreased in the CD4+ T cells of DCM patients compared with that of the controls. The transfection of T cells with an miR-451a mimic inhibited their activation and proliferation, whereas an miR-451a inhibitor produced the opposite effects. Myc was directly inhibited by miR-451a via interaction with its 3'-UTR, thus identifying it as an miR-451a target in T cells. The knockdown of Myc suppressed the activation and proliferation of T cells, and the expression of Myc was significantly up-regulated at the mRNA level in CD4+ T cells from patients with DCM. A strong inverse correlation was observed between the Myc mRNA expression and miR-451a transcription level. Our data suggest that the down-regulation of miR-451a contributes to the activation and proliferation of CD4+ T cells by targeting the transcription factor Myc in DCM patients and may contribute to the immunopathogenesis of DCM.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Myc (c-Myc); T helper cells; cardiovascular disease; inflammation; microRNA (miRNA)

Mesh:

Substances:

Year:  2016        PMID: 27974462      PMCID: PMC5392590          DOI: 10.1074/jbc.M116.765107

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  MicroRNA-451 exacerbates lipotoxicity in cardiac myocytes and high-fat diet-induced cardiac hypertrophy in mice through suppression of the LKB1/AMPK pathway.

Authors:  Yasuhide Kuwabara; Takahiro Horie; Osamu Baba; Shin Watanabe; Masataka Nishiga; Shunsuke Usami; Masayasu Izuhara; Tetsushi Nakao; Tomohiro Nishino; Kinya Otsu; Toru Kita; Takeshi Kimura; Koh Ono
Journal:  Circ Res       Date:  2014-10-31       Impact factor: 17.367

2.  Hypertonic stress increases T cell interleukin-2 expression through a mechanism that involves ATP release, P2 receptor, and p38 MAPK activation.

Authors:  William H Loomis; Sachiko Namiki; Rennolds S Ostrom; Paul A Insel; Wolfgang G Junger
Journal:  J Biol Chem       Date:  2002-12-02       Impact factor: 5.157

3.  T-cell Activation Induces Dynamic Changes in miRNA Expression Patterns in CD4 and CD8 T-cell Subsets.

Authors:  Nato Teteloshvili; Katarzyna Smigielska-Czepiel; Bart-Jan Kroesen; Elisabeth Brouwer; Joost Kluiver; Annemieke M H Boots; Anke van den Berg
Journal:  Microrna       Date:  2015

4.  MicroRNA-451 induces epithelial-mesenchymal transition in docetaxel-resistant lung adenocarcinoma cells by targeting proto-oncogene c-Myc.

Authors:  Dongqin Chen; Jiayuan Huang; Kai Zhang; Banzhou Pan; Jing Chen; Wei De; Rui Wang; Longbang Chen
Journal:  Eur J Cancer       Date:  2014-10-10       Impact factor: 9.162

5.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.

Authors:  Barry J Maron; Jeffrey A Towbin; Gaetano Thiene; Charles Antzelevitch; Domenico Corrado; Donna Arnett; Arthur J Moss; Christine E Seidman; James B Young
Journal:  Circulation       Date:  2006-03-27       Impact factor: 29.690

6.  The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation.

Authors:  Ruoning Wang; Christopher P Dillon; Lewis Zhichang Shi; Sandra Milasta; Robert Carter; David Finkelstein; Laura L McCormick; Patrick Fitzgerald; Hongbo Chi; Joshua Munger; Douglas R Green
Journal:  Immunity       Date:  2011-12-23       Impact factor: 31.745

7.  MicroRNA-126 regulates DNA methylation in CD4+ T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1.

Authors:  Sha Zhao; Yu Wang; Yunsheng Liang; Ming Zhao; Hai Long; Shu Ding; Heng Yin; Qianjin Lu
Journal:  Arthritis Rheum       Date:  2011-05

8.  Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases.

Authors:  Perry Elliott; Bert Andersson; Eloisa Arbustini; Zofia Bilinska; Franco Cecchi; Philippe Charron; Olivier Dubourg; Uwe Kühl; Bernhard Maisch; William J McKenna; Lorenzo Monserrat; Sabine Pankuweit; Claudio Rapezzi; Petar Seferovic; Luigi Tavazzi; Andre Keren
Journal:  Eur Heart J       Date:  2007-10-04       Impact factor: 29.983

9.  Targeted deletion of microRNA-22 promotes stress-induced cardiac dilation and contractile dysfunction.

Authors:  Priyatansh Gurha; Cei Abreu-Goodger; Tiannan Wang; Maricela O Ramirez; Ana L Drumond; Stijn van Dongen; Yuqing Chen; Nenad Bartonicek; Anton J Enright; Brendan Lee; Robert J Kelm; Anilkumar K Reddy; George E Taffet; Allan Bradley; Xander H Wehrens; Mark L Entman; Antony Rodriguez
Journal:  Circulation       Date:  2012-05-08       Impact factor: 29.690

Review 10.  Strategically targeting MYC in cancer.

Authors:  Valeriya Posternak; Michael D Cole
Journal:  F1000Res       Date:  2016-03-29
View more
  10 in total

1.  Downregulation of miRNA-451a Promotes the Differentiation of CD4+ T Cells towards Th2 Cells by Upregulating ETS1 in Childhood Asthma.

Authors:  Tianyue Wang; Qianlan Zhou; Yunxiao Shang
Journal:  J Innate Immun       Date:  2020-12-03       Impact factor: 7.349

2.  MicroRNA-451a attenuates angiotensin II-induced cardiac fibrosis and inflammation by directly targeting T-box1.

Authors:  Hao-Yuan Deng; Ze-Yin He; Zhi-Chao Dong; Yun-Long Zhang; Xiao Han; Hui-Hua Li
Journal:  J Physiol Biochem       Date:  2021-12-01       Impact factor: 4.158

3.  MicroRNA-126 deficiency enhanced the activation and function of CD4+ T cells by elevating IRS-1 pathway.

Authors:  F Chu; Y Hu; Y Zhou; M Guo; J Lu; W Zheng; H Xu; J Zhao; L Xu
Journal:  Clin Exp Immunol       Date:  2017-10-30       Impact factor: 4.330

Review 4.  Control of Immunoregulatory Molecules by miRNAs in T Cell Activation.

Authors:  Ana Rodríguez-Galán; Lola Fernández-Messina; Francisco Sánchez-Madrid
Journal:  Front Immunol       Date:  2018-09-25       Impact factor: 7.561

Review 5.  MicroRNAs in Cardiac Diseases.

Authors:  Robin M W Colpaert; Martina Calore
Journal:  Cells       Date:  2019-07-18       Impact factor: 6.600

Review 6.  Metabolism and Autoimmune Responses: The microRNA Connection.

Authors:  Alessandra Colamatteo; Teresa Micillo; Sara Bruzzaniti; Clorinda Fusco; Silvia Garavelli; Veronica De Rosa; Mario Galgani; Maria Immacolata Spagnuolo; Francesca Di Rella; Annibale A Puca; Paola de Candia; Giuseppe Matarese
Journal:  Front Immunol       Date:  2019-08-28       Impact factor: 7.561

7.  CRISPR Editing Enables Consequential Tag-Activated MicroRNA-Mediated Endogene Deactivation.

Authors:  Panayiota L Papasavva; Petros Patsali; Constantinos C Loucari; Ryo Kurita; Yukio Nakamura; Marina Kleanthous; Carsten W Lederer
Journal:  Int J Mol Sci       Date:  2022-01-19       Impact factor: 5.923

8.  The accumulation of exosome-associated microRNA-1246 and microRNA-150-3p in human red blood cell suspensions.

Authors:  Yujie Kong; Xue Tian; Rui He; Chenyue Li; Haixia Xu; Li Tian; Zhong Liu
Journal:  J Transl Med       Date:  2021-05-27       Impact factor: 5.531

9.  Extracellular Vesicles in Synovial Fluid from Rheumatoid Arthritis Patients Contain miRNAs with Capacity to Modulate Inflammation.

Authors:  Andrew D Foers; Alexandra L Garnham; Simon Chatfield; Gordon K Smyth; Lesley Cheng; Andrew F Hill; Ian P Wicks; Ken C Pang
Journal:  Int J Mol Sci       Date:  2021-05-06       Impact factor: 5.923

Review 10.  An update on the roles of immune system-derived microRNAs in cardiovascular diseases.

Authors:  Luke B Roberts; Puja Kapoor; Jane K Howard; Ajay M Shah; Graham M Lord
Journal:  Cardiovasc Res       Date:  2021-11-01       Impact factor: 10.787

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.